SCHEMBL1576740

SCHEMBL1576740

COC(C(=O)O)=C(C)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
SRC P12931 1/20 0.48
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 1/20 0.47
GLA P06280 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP19A1 P11511 3/20 0.46
POLB P06746 1/20 0.46
CES1 P23141 4/20 0.45
CES2 O00748 3/20 0.45
LMNA P02545 2/20 0.43
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576791 0.81 TSHR (0.56) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL6204756 0.80 ELANE (0.52) TSHRALDH1A1MAPTKMT2AKDM4E
SCHEMBL457034 0.79 TSHR (0.54) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL27892981 0.78 TSHR (0.52) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL27923392 0.78 TSHR (0.52) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL27876289 0.78 TSHR (0.52) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL14868116 0.77 TSHR (0.56) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL15081529 0.77 TSHR (0.56) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL14868118 0.77 TSHR (0.56) TSHRSRCALDH1A1MAPTKMT2A
SCHEMBL417437 0.76 TSHR (0.50) TSHRSRCALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1584323-B1 Use of N-hydroxyalkyl-O-benzylchitosans in hair treatment WELLA AG (DE) 2007-10-24 EP claimed
EP-1715842-A1 HAIR-TREATMENT AGENT COMPRISING TERPOLYMER FROM VINYL PYRROLIDONE, METHACRYLAMIDE AND VINYL IMIDAZOLE AND ACTIVE INGREDIENTS AND ADDITIVES Wella Aktiengesellschaft (DE) 2006-11-02 EP claimed
US-20050226838-A1 Hair treatment compositions containing N-hydroxy-alkyl-O-benzyl chitosans and methods of using same WELLA AG (DE) 2005-10-13 US claimed
EP-1584323-A1 Use of N-hydroxyalkyl-O-benzylchitosans in hair treatment Wella Aktiengesellschaft (DE) 2005-10-12 EP claimed
WO-2005082322-A1 HAIR-TREATMENT AGENT COMPRISING TERPOLYMER FROM VINYL PYRROLIDONE, METHACRYLAMIDE AND VINYL IMIDAZOLE AND ACTIVE INGREDIENTS AND ADDITIVES WELLA AKTIENGESELLSCHAFT (DE) 2005-09-09 WO claimed
CN-108368098-B Microbicidal oxadiazole derivatives 先正达参股股份有限公司 2022-01-28 CN disclosed
US-10182980-B2 Method of making an amino silicone nanoemulsion THE PROCTER & GAMBLE COMPANY (US) 2019-01-22 US disclosed
EP-2090295-B2 Method and composition for reducing the drying time of hair PROCTER & GAMBLE (US) 2018-08-22 EP disclosed
US-9982223-B2 Amino silicone nanoemulsion THE PROCTER & GAMBLE COMPANY (US) 2018-05-29 US disclosed
EP-3250292-A1 A METHOD OF MAKING AN AMINO SILICONE NANOEMULSION The Procter and Gamble Company (US) 2017-12-06 EP disclosed
EP-3250673-A1 AMINO SILICONE NANOEMULSION The Procter and Gamble Company (US) 2017-12-06 EP disclosed
US-9717676-B2 Amino silicone nanoemulsion THE PROCTER & GAMBLE COMPANY (US) 2017-08-01 US disclosed
US-20080020004-A1 Hair-Treatment Agent Comprising Terpolymer Of Vinylpyrrolidone, Methacrylamide And Vinylimidazole And Active Ingredients And Additives WELLA AG (DE) 2008-01-24 US disclosed
EP-1584323-B1 Use of N-hydroxyalkyl-O-benzylchitosans in hair treatment WELLA AG (DE) 2007-10-24 EP disclosed
EP-1765273-A1 USE OF COMBINATIONS CONTAINING OXOCARBOXYLIC ACIDS FOR DEODORISING SKIN AND HAIR Wella Aktiengesellschaft (DE) 2007-03-28 EP disclosed
EP-1715842-A1 HAIR-TREATMENT AGENT COMPRISING TERPOLYMER FROM VINYL PYRROLIDONE, METHACRYLAMIDE AND VINYL IMIDAZOLE AND ACTIVE INGREDIENTS AND ADDITIVES Wella Aktiengesellschaft (DE) 2006-11-02 EP disclosed
WO-2006005561-A1 USE OF COMBINATIONS CONTAINING OXOCARBOXYLIC ACIDS FOR DEODORISING SKIN AND HAIR WELLA AKTIENGESELLSCHAFT (DE) 2006-01-19 WO disclosed
US-20050226838-A1 Hair treatment compositions containing N-hydroxy-alkyl-O-benzyl chitosans and methods of using same WELLA AG (DE) 2005-10-13 US disclosed
EP-1584323-A1 Use of N-hydroxyalkyl-O-benzylchitosans in hair treatment Wella Aktiengesellschaft (DE) 2005-10-12 EP disclosed
WO-2005082322-A1 HAIR-TREATMENT AGENT COMPRISING TERPOLYMER FROM VINYL PYRROLIDONE, METHACRYLAMIDE AND VINYL IMIDAZOLE AND ACTIVE INGREDIENTS AND ADDITIVES WELLA AKTIENGESELLSCHAFT (DE) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050226838-A1 Hair treatment compositions containing N-hydroxy-alkyl-O-benzyl chitosans and methods of using same CYP8B1, HAAO, TYR TSHR 4502/4885SRC 1550/4885ALDH1A1 1251/4885
US-10182980-B2 Method of making an amino silicone nanoemulsion SMURF1, SMURF2, ASNS TSHR 4215/4885SRC 1713/4885ALDH1A1 4749/4885
US-20080020004-A1 Hair-Treatment Agent Comprising Terpolymer Of Vinylpyrrolidone, Methacrylamide And Vinylimidazole And Active Ingredients And Additives PLOD3, POLR1C, PTMA TSHR 1689/4885SRC 868/4885ALDH1A1 1332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.